Toshiba America Medical Systems Inc.’s Aquilion Lightning computed tomography (CT) system was U.S. Food and Drug Administration (FDA)-cleared with a more powerful 50 kw generator.

A five-year study shows that stereotactic body radiation therapy (SBRT) offers a higher cure rate for prostate cancer than more traditional approaches, according to researchers at UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center.

Elekta, Philips and The Netherlands Cancer Institute, announced the installation of a 1.5 Tesla magnetic resonance (MR)-guided linear accelerator (MR-linac) system.

Delray Medical Center, Delray Beach, Fla., has reached agreement with Proton International (PI) to build a one-room proton therapy treatment center serving the South Florida corridor.

Brainlab AG and Dalhousie University, Atlantic Canada’s leading research-intensive university, have entered into an exclusive intellectual property license agreement for integration with next-generation radiosurgery software.

RefleXion Medical, a medical equipment company developing the first biology-guided radiotherapy system for targeted, personalized cancer treatment, announced that it has closed a $46 million Series B round of funding.

The American College of Radiology (ACR), as a member of a coalition of leading medical societies, provided peripheral arterial disease (PAD) treatment recommendations to the Medicare Evidence Development Coverage Advisory Committee (MEDCAC).


With all areas of healthcare now migrating to electronic medical record (EMR) platforms, the data they contain can be mined to use increasingly sophisticated analytics software. This includes pulling information to improve department or hospital management, quality assurance to boost outcomes and efficiency, and even the ability to identify patients who are ideal referrals for new clinical programs such as low-dose lung computed tomography (CT) cancer screenings, or candidates for peripheral artery disease revascularization. 


As chronic traumatic encephalopathy (CTE) stands in the national spotlight for high impact sports, the University of California, Irvine has partnered with Toshiba America Medical Systems Inc. for a first-of-its-kind study of cerebral microbleeds (CMB) in high school football players as a potential precursor to CTE.

Physicians have begun treating patients with the Mevion S250 proton therapy system at The Marjorie and Leonard Williams Center for Proton Therapy at UF Health Cancer Center-Orlando Health in Florida.

Subscribe Now